FEB 2015 ARTICLE LIST >>
PharmaTutor (February- 2015)
Print-ISSN: 2394 - 6679
e-ISSN: 2347 - 7881
(Volume 3, Issue 2)
Received On: 22/11/2014; Accepted On: 26/11/2014; Published On: 01/02/2015
AUTHORS: M. Sushma*, T. V. V. Vidyadhar, M. Babu M.D., R. Mohan raj
*Department of Pharmacy Practice,
Raghavendra Institute of Pharmaceutical Education & Research, RIPER.
K R Palli Cross, Near S.K University, Anantapuramu District, Andhra Pradesh
sushma.banthi@gmail.com
ABSTRACT: Diabetic retinopathy, one of the leading causes of blindness for diabetic patients between the ages of 20 and 74. The clinical research provides control of blood glucose and blood pressure substantially reduces the risk of blindness due to diabetic retinopathy, many patients develop this eye disease and are at risk for serious vision loss, sometimes even despite outstanding metabolic control. Diabetic retinopathy occurs when high blood glucose damages the micro blood vessels in the retina which leads to leakage of small amounts of blood, serum, blood fats and blood proteins proliferates to vision loss and formation of scar tissue. Here the retinal laser therapy also called aslaser photocoagulation has greatly reduced the number of patients who lose vision to Diabetic retinopathy. Laser photocoagulation refers to the precise and concentrated application of high energy light, typically of a single wavelength called monochromatic light.
<
How to cite this article: M Sushma, TVV Vidyadhar, M Babu, R Mohanraj; A Review on Role of Laser Photocoagulation Therapy in Diabetic Retinopathy; PharmaTutor; 2015; 3(2); 8-18
[ABSTRACT WITH CITATION] [VIEW AS HTML]
REFERENCES:
1. Diabetic retinopathy guidelines; Royal College of Ophthalmologists (Dec 2012)
2. Lawrence, Peter F; Bell, Richard M; Dayton, Merril T (2006). Essentials of surgical specialities. Lippincott Williams & Wilkins
3. (Ockrim Z, Yorston D; managing diabetic retinopathy. BMJ. 2010 Oct 25; 341:c5400. Doi: 10.1136/bmj.c5400.
4. Parodi MB, Bandello F. Branch retinal vein occlusion: classification and treatment. Ophthalmological. 2009; 223(5):298-305. [Medline]
5. Diabetes - type 2; NICE CKS, July 2010
6. Bhavsar AR et al; Diabetic Retinopathy, Medscape, Jun 2012
7. Mohamed Q, Gillies MC, Wong TY; Management of diabetic retinopathy: a systematic review. JAMA. 2007 Aug 22;298(8):902-16.9
8. Liew G, Mitchell P, Wong TY; Systemic management of diabetic retinopathy. BMJ. 2009 Feb 12; 338:b441. Doi: 10.1136/bmj.b441.
9. geteyesmart.org/eyesmart/diseases/diabetic-retinopathy.cfm
10. Virgili G, Parravano M, Menchini F, et al; Antiangiogenic therapy with anti-vascular endothelial growth factor modalities for diabetic macular oedema. Cochrane Database System Rev. 2012 Dec 12; 12:CD007419. Doi: 10.1002/14651858.CD007419.pub3.
11. midatlanticretina.com/retinal-laser-photocoagulation.php
12. J H Lock /University of Malaya Eye Research Centre (UMERC), Department of Ophthalmology/Retinal Laser Photocoagulation /CONTINUING MEDICAL EDUCATION /Med J Malaysia Vol 65 No 1 March 2010
13. Kulkarni GR. Laser-tissue interaction studies for medicine. Bulletin of Material Sciences 1988; 11: 239-44.
14. Krauss JM, Puliafito CA. Lasers in ophthalmology. Lasers Surg Med 1995; 17: 102-59.
15. L'Esperance FA, Jr. An opthalmic argon laser photocoagulation system: design, construction, and laboratory investigations. Trans Am Ophthalmol Soc 1968; 66: 827-904
16. Dyer DS, Bressler SB, Bressler NM. The role of laser wavelength in the treatment of vitreoretinal diseases. Curr Opin Ophthalmol 1994; 5: 35-43.
17. Tasman W, Jaeger EA. Duane's Clinical Ophthalmology. Philadelphia: Lippincott Williams & Wilkins, 2005.
18. Freeman WR, Bartsch DU. New ophthalmic lasers for the evaluation and treatment of retinal disease. Aust N Z J Ophthalmol 1993; 21: 139-46
19. McAllister IL, Constable IJ. Laser-induced chorioretinal venous anastomosis for treatment of nonischemic central retinal vein occlusion. Arch Ophthalmol 1995; 113: 456-62.
20. Einar Stefánsson /The Mechanism of Retinal Photocoagulation /Posterior Segment Retina /EUROPEAN OPHTHALMIC REVIEW /TOUCH BRIEFINGS 2008
21. Novack RL, Stefansson E, Hatchell DL, Intraocular pressure effects on optic nerve-head oxidative metabolism measured in vivo, Graefes Arch Clin Exp Ophthalmol, 1990;228:128–33
22. Molnar I, Poitry S, Tsacopoulos M, et al., Effect of laser photocoagulation on oxygenation of the retina in miniature pigs, Invest Ophthalmol Vis Sci, 1985;26:1410–14
23. Landers MB III, Stefansson E, Wolbarsht ML, Panretinal photocoagulation and retinal oxygenation, Retina, 1982;2:167–75.
24. Augustin AJ, Keller A, Koch F, et al., Effect of retinal coagulation status on oxidative metabolite and VEGF in 208 patients with proliferative diabetic retinopathy, Klin Monatsbl Augenheilkd, 2001;218:89–94
25. Lip PL, Belgore F, Blann AD, et al., Plasma VEGF and soluble VEGF receptor FLT-1 in proliferative retinopathy: relationship to endothelial dysfunction and laser treatment, Invest Ophthalmol Vis Sci, 2000;41:2115–19
26. Pournaras CJ, Retinal oxygen distribution. Its role in the physiopathology of vasoproliferative microangiopathies, Retina, 1995; 15:332–47.
.png)
